WatchPAT is a simple, highly accurate, fast and reliable FDA-cleared Home Sleep Test (HST) for the diagnosis of sleep apnea, a major comorbidity to many cardiovascular diseases.
Itamar Medical Ltd is a medical technology company focused on the development, marketing and sales of diagnostic products based on its proprietary PAT platform technology, developed by a team of leading clinicians in sleep medicine and cardiology together with biomedical engineers and physicists. Read More...
This issue examines the importance of sleep screening in diagnosing OSA from the perspective of both physician and patient. Cardiologist Dr. Jeffrey Shanes discusses how screening is a priority in his practice, in response to the growing number of patients suffering with OSA and AFib. We also hear the moving story of a patient’s decision to finally take a home sleep apnea test, and his subsequent diagnosis and treatment for both OSA and AFib that have led to a healthier life.
In this issue, we look at the coding procedures and requirements for HSAT. Introducing Sleep Diagnostics to the Cardiology care point, requires some specific adjustments. We continue to share the challenge of the “old way” of referring cardiac patients to the traditional sleep lab as a first line diagnostic, as discussed in conversations with cardiologist Rick Pumill, MD, and Omar Burschtin, MD, Medical Director, Sleep Medicine at Mount Sinai Hospital in New York City.
“The WP may be a clinically accurate diagnostic method for OSA in adolescents whether we used the respiratory
scoring rules for children or adults. Additional WP200 feasibility studies are needed with more adolescents”.
Itamar Medical Ltd.
9 Halamish Street,
Caesarea, 3088900 Israel